Psychosis and delirium following metabolife use
- PMID: 12473963
Psychosis and delirium following metabolife use
Abstract
Weight gain is a well-known complication of antipsychotic therapy, especially when using newer atypical antipsychotic agents. In addition to the risk of medical comorbidities associated with weight gain, such as diabetes mellitus and cardiovascular disease, a further risk of antipsychotic-induced weight gain is that patients may resort to over-the-counter preparations to aid in weight loss. We report on a case in which a patient with schizophrenia began using Metabolife, an herbal preparation containing ephedra, for weight reduction and subsequently developed an exacerbation of his psychosis with superimposed delirium. We mention several relatively safe alternatives to herbal supplements for weight loss, as well as emphasize the need for clinicians to educate their patients regarding the potential risks of over-the-counter weight loss agents.
Similar articles
-
Weight gain associated with antipsychotic drugs.J Clin Psychiatry. 1999;60 Suppl 21:20-4. J Clin Psychiatry. 1999. PMID: 10548138
-
Reversal of antipsychotic-associated weight gain.J Clin Psychiatry. 2003 Aug;64(8):907-12. doi: 10.4088/jcp.v64n0808. J Clin Psychiatry. 2003. PMID: 12927005
-
[Weight gain in patients with schizophrenia and schizoaffective disorder induced by the long-term treatment with atypical antipsychotics].Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(9):52-6. Zh Nevrol Psikhiatr Im S S Korsakova. 2008. PMID: 18833173 Russian.
-
Antipsychotic-associated weight gain and clinical outcome parameters.J Clin Psychiatry. 2001;62 Suppl 7:11-21. J Clin Psychiatry. 2001. PMID: 11346191 Review.
-
Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Epub 2010 Mar 16. Ann Pharmacother. 2010. PMID: 20233913 Review.
Cited by
-
Coronavirus Disease 2019 and Herbal Therapy: Pertinent Issues Relating to Toxicity and Standardization of Phytopharmaceuticals.Rev Bras Farmacogn. 2021;31(2):142-161. doi: 10.1007/s43450-021-00132-x. Epub 2021 Mar 11. Rev Bras Farmacogn. 2021. PMID: 33727754 Free PMC article. Review.
-
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety.Front Pharmacol. 2014 Jan 10;4:177. doi: 10.3389/fphar.2013.00177. eCollection 2014 Jan 10. Front Pharmacol. 2014. PMID: 24454289 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical